Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
R.J. Lantz, Jr., in Pharmaceutical Dosage Forms: Tablets, Volume 2, Marcel Dekker, New York (1990) 117.
2. R.H. Müller, C. Jacobs, O. Kayser, Adv. Drug Deliv. Rev. 47 (2001) 3.
H.W. Bosch, D.M. Marcera, R.L. Mueller, J.R. Swanson, D.S. Mishra, U.S. Patent No. 5,510,118 (1996).
J.R. Swanson, H.W. Bosch, K.J. Illig, D.M. Marcera, R.L. Mueller, U.S. Patent No. 5,543,133 (1996).
R.J. Lantz, Jr., in Pharmaceutical Dosage Forms: Tablets, Volume 2, Marcel Dekker, New York (1990) 123.
G.G. Liversidge, K.C. Cundy, J.F. Bishop, D.A. Czekai, U.S. Patent No. 5,145,684 (1992).
J.A. Bruno, B.D. Doty, E. Gustow, K.J. Illig, N. Rajagopalan, P. Sarpotdar, U.S. Patent No. 5,518,187 (1996).
8. E. Matijević, Chem. Mater. 5 (1993) 412.
R.E. Sievers, U. Karst, U.S. Patent No. 6,095,134 (2000).
10. S. D. Škapin, E. Matijević, J. Colloid Interface Sci. 272 (2004) 90.
11. L. Joguet, E. Matijević, J. Colloid Interface Sci. 250 (2002) 503.
12. F. Ruch, E. Matijević, J. Colloid Interface Sci. 229 (2000) 207.
13. H.W. Bosch, S. Škapin, E. Matijević, Colloids Surf. A Physicochem. Eng. Aspects 250 (2004) 43.
Fosamax® (alendronate sodium tablets), Merck, in Physicians' Desk Reference®, 58 Edition, Thomson PDR, Montvale, NJ (2004) 1990.
15. A. Noyes, W.R. Whitney, J. Am. Chem. Soc. 19 (1897) 930.
J.D. Pruitt, N.P. Ryde, American Association of Pharmaceutical Scientists, Annual Meeting and Exposition, Baltimore, MD (2004).
17. L.F. Prescott, R.F. Steel, W.R. Ferrier, Clin. Pharmacol. Ther. 11 (1970) 496.
18. G.G. Liversidge, K.C. Cundy, Int. J. Pharm 125 (1995) 91.
Megace ES® (megestrol acetate), Par Pharmaceutical, in PDR® Electronic Library, Thomson Micromedex, Greenwood Village, CO (2006).
Tricor® (fenofibrate tablets), Abbott Laboratories, in Physicians' Desk Reference®, 58 Edition, Thomson PDR, Montvale, NJ (2004) 522.
U. S. Food and Drug Administration, Center for Drug Evaluation and Research, NDA 019304, supplement no. 001, action date 02/09/1998.
U. S. Food and Drug Administration, Center for Drug Evaluation and Research, NDA 021203, supplement no. 000, action date 09/04/2001.
U. S. Food and Drug Administration, Center for Drug Evaluation and Research, NDA 021656, supplement no. 000, action date 11/05/2004.
U. S. Food and Drug Administration, Center for Drug Evaluation and Research, NDA 021695, supplement no. 000, action date 11/30/2004.
U. S. Food and Drug Administration, Center for Drug Evaluation and Research, NDA 021350, supplement no. 000, action date 05/07/2005.
Mobic® (meloxicam), Boehringer Ingelheim Pharmaceuticals, in Physicians' Desk Reference®, 58 Edition, Thomson PDR, Montvale, NJ (2004) 1017.
J.D. Pruitt, American Association of Pharmaceutical Scientists, Annual Meeting and Exposition, Salt Lake City, UT (2003).
H.W. Bosch, E.R. Cooper, S.L. McGurk, U. S. Patent No. 6,428,814 (2002).
S.B. Ruddy, W.M. Eickhoff, G. Liversidge, M.E. Roberts, U.S. Patent No. 5,593,657 (1997).
The United States Pharmacopeia (USP 26/NF 21), The United States Pharmacopeial Convention, Rockville, MD (2003) 1471.
Taxotere® (docetaxel), Sanofi‐Aventis, in PDR® Electronic Library, Thomson Micromedex, Greenwood Village, CO (2006).
32. E. Merisko-Liversidge, G.G. Liversidge, E.R. Cooper, Eur. J. Pharm. Sci. 18 (2003) 113.
J.P. Donnelly, J.W. Mouton, N.M.A. Blijlevens, A. Smiets, P.E. Verweij, B.E. Depauw, American Society for Microbiology, 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL (2001).
L.R. Cantilena, Jr., unpublished results.
G.G. Liversidge, E.R. Cooper, J.M. Shaw, G.L. McIntire, U. S. Patent No. 5,318,767 (1994).
G. Wolf, U.S. Patent No. 5,496,536 (1996).
A.J. Hickey, in Modern Pharmaceutics, G.S. Banker, C.T. Rhodes (eds.). Marcel Dekker, New York (2002) 480.
Pulmicort Turbuhaler 200 mcg (budesonide inhalation powder), AstraZeneca LP, in Physicians' Desk Reference®, 58 Edition, Thomson PDR, Montvale, NJ (2004) 642.
Flovent® Rotadisk® (fluticasone propionate inhalation poweder), GlaxoSmithKline, in Physicians' Desk Reference®, 58 Edition, Thomson PDR, Montvale, NJ (2004) 1507.
40. D.A. Edwards, J. Hanes, G. Caponetti, J. Hrkach, A. Ben-Jebria, M.L. Eskew, J. Mintzes, D. Deaver, N. Lotan, R. Langer, Science 276 (1997) 1868.
H.W. Bosch, American Association of Pharmaceutical Scientists, Annual Meeting and Exposition, New Orleans, LA (1999).
42. K.D. Ostrander, H.W. Bosch, D.M. Marcera, Eur. J. Pharm. Biopharm. 48 (1999) 207.
H.W. Bosch, D.M. Bondanza, R.A. Caspar, D.L. Gardner, F.A. Leith, International Society for Aerosols in Medicine Focus Symposium, Tours, France (1996).
44. C. Lipinski, Am. Pharm. Rev. 5 (2002) 82.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Bosch, H. (2008). Pharmaceutical Applications of Finely Dispersed Systems. In: Matijevic, E. (eds) Medical Applications of Colloids. Springer, New York, NY. https://doi.org/10.1007/978-0-387-76921-9_3
Download citation
DOI: https://doi.org/10.1007/978-0-387-76921-9_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-76920-2
Online ISBN: 978-0-387-76921-9
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)